Abstract

Aberrant expression of FAM64A was correlated with cell proliferation in various cancer types. We examined the expression of FAM64A and the upstream gene miR-493 in OS. The functions of miR-493 were revealed through extensive experiments. We found an increase of FAM64A gene and protein in OS tissues. Overexpression of FAM64A resulted in promoting tumor proliferation, migration, and invasion. The miR-493 targeted and negatively regulated FAM64A. Our data showed that upregulation of FAM64A in OS correlated with poor prognosis.

Highlights

  • Osteosarcomas are originated from primitive mesenchymal cells and defined as the most prevalent primary solid tumor of the bone

  • Xu et al found that FAM64A served as a positive regulator of STAT3, which is linked to various cancer types [7]

  • We discovered the tumorderived miR-493 targeted to FAM64A and regulated the cell growth and metastasis of OS

Read more

Summary

Introduction

Osteosarcomas are originated from primitive mesenchymal cells and defined as the most prevalent primary solid tumor of the bone. CATS (FAM64A) is confirmed to be highly expressed in leukemia, lymphoma, and a range of tumor cell lines. It has been reported that its protein levels have intense relationship with proliferation in both tumor cells and nonmalignant cells. Silencing of FAM64A resulted in decreased proliferation and cell cycle progression of hematopoietic cells [2]. Xu et al found that FAM64A served as a positive regulator of STAT3, which is linked to various cancer types [7]. We tried to find a new mechanism that interacts with FAM64A in OS. We discovered the tumorderived miR-493 targeted to FAM64A and regulated the cell growth and metastasis of OS

Materials and Methods
Results
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.